In the training cohort of 490 patients, high PKM2 expression was more likely to present advanced clinical characters, including higher serum α-Fetoprotein level (P < 0.001), advanced clinical stage (P = 0.004), vascular invasion (P = 0.001) and tumor size (P = 0.042). The gene discussed is PKM; the disease is neoplasm.